PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block ...

Diabetic retinopathy is the leading cause of blindness in working-age adults in the U.S. and is a complication of diabetes.

As India grapples with an escalating diabetes crisis, with 101 million1 diagnosed and 136 million with pre-diabetes, the ...

Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibitor, ...

Integrating IRIS technologies will allow Topcon to improve retinal disease diagnostics and referrals from primary care ...

Statistical analysis showed a strong association between advanced diabetic retinopathy and an increased likelihood of heart ...

Cloudy vision can develop for several reasons, including cataracts, macular degeneration, and inflammatory eye conditions.

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...

Researchers at Edith Cowan University (ECU) have developed a cutting-edge Artificial Intelligence (AI) system that could ...

AEYE Health, the leader in AI-powered retinal diagnostics, announces the appointment of Dr. Pamela F. Gallin as its Chief ...

Sure, you probably know that feeling super thirsty or peeing a lot can flag high blood sugar. But the truth? Many women don’t ...

USA: A new study has found that survival models using electronic health record (EHR) data can accurately predict the ...